中医药
脂肪肝
医学
氧化应激
机制(生物学)
线粒体
疾病
脂质代谢
肝功能
生物信息学
内科学
药理学
病理
生物
替代医学
生物化学
哲学
认识论
作者
Qiong Ma,Anhua Shi,Xi Zhao,Wenling Chen
出处
期刊:PubMed
[National Institutes of Health]
日期:2022-10-01
卷期号:47 (19): 5113-5120
被引量:1
标识
DOI:10.19540/j.cnki.cjcmm.20220704.601
摘要
Non-alcoholic fatty liver disease(NAFLD), as a metabolic stress liver injury disease, is one of the most common chronic liver diseases, which seriously threatens people's health. The pathogenesis of NAFLD is very complex. A large number of studies show that the hepatic mitochondrial dysfunction leads to the disorder of hepatic glucose and lipid metabolism, oxidative stress, and inflammation, thus inducing hepatocyte apoptosis, which plays an important role in the progression of NAFLD. In recent years, researchers have begun to focus on developing drugs that slowed the progression of NAFLD by regulating the hepatic mitochondrial function. Chinese medicine has a good curative effect on the treatment of NAFLD, with the advantages of high safety and few side effects. Various studies have shown that Chinese medicine prevented and treated NAFLD by regulating the mitochondrial function. Therefore, this paper summarized the relationship between NAFLD and mitochondria, and the mechanism of Chinese medicine(single Chinese medicine, Chinese medicine monomer, and Chinese medicine compound prescription) in the prevention and treatment of NAFLD by regulating mitochondrial function. This paper is expected to provide references for clinical application of traditional Chinese medicine in the treatment of NAFLD by regulating mitochondrial function.
科研通智能强力驱动
Strongly Powered by AbleSci AI